Cargando…
Long-term assist device patients admitted to ICU: Tips and pitfalls
Left ventricular assist device (LVAD) therapy is well-established in the treatment of end-stage cardiac failure. Indications are bridge to transplant (BTT), bridge to candidacy (BTC), bridge to recovery (BTR), and destination therapy (DT). The durability and adverse event (AE) rate of LVADs have imp...
Autores principales: | Morshuis, Michiel, Fox, Hendrik, Lauenroth, Volker, Schramm, Rene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175735/ https://www.ncbi.nlm.nih.gov/pubmed/37188121 http://dx.doi.org/10.1016/j.jointm.2022.10.004 |
Ejemplares similares
-
Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022) -
Safety, Mortality, and Hemodynamic Impact of Patients with MitraClip Undergoing Left Ventricular Assist Device Implantation
por: Fox, Henrik, et al.
Publicado: (2021) -
Bacteriophage-Enriched Galenic for Intrapericardial Ventricular Assist Device Infection
por: Rojas, Sebastian V., et al.
Publicado: (2022) -
Facilitating heart transplantability in an end-stage heart failure patient with brain abscess and infected left ventricle assist device—A unique case report
por: Ibrahim, Mohamad, et al.
Publicado: (2020) -
Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
por: Gyoten, Takayuki, et al.
Publicado: (2020)